Literature DB >> 12432943

Function of prostanoid receptors: studies on knockout mice.

Takuya Kobayashi1, Shuh Narumiya.   

Abstract

Prostanoids consisting of the prostaglandins (PGs) and the thromboxanes (TXs) are the cyclooxygenase metabolites of arachidonic acid. They exert a range of actions mediated by their respective receptors expressed in the target cells. The receptors include the DP, EP, FP, IP and TP receptors for PGD, PGE, PGF, PGI and TXA, respectively. Furthermore, EP is subdivided into four subtypes, EP1, EP2, EP3 and EP4, which are encoded by different genes and differ in their responses to various agonists and antagonists. Recent developments in the molecular biology of the prostanoid receptors have enabled the investigation of physiological roles of each receptor by disruption of the respective gene. At this point, all the eight types and subtypes of the prostanoid receptors have been individually knocked out in mice, and various phenotypes have been reported for each strain. Here, we review the findings obtained in these studies. The results from these knockout mice studies may be useful in the development of novel therapeutics that can selectively manipulate actions mediated by each receptor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12432943     DOI: 10.1016/s0090-6980(02)00055-2

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  46 in total

1.  Role of prostaglandins in fibroblast activation and fibrosis.

Authors:  Richard Stratton; Xu Shiwen
Journal:  J Cell Commun Signal       Date:  2010-03-26       Impact factor: 5.782

2.  Serum concentrations of cyclooxygenase-2 in patients with systemic sclerosis: association with lower frequency of pulmonary fibrosis.

Authors:  Iman H Bassyouni; Roba M Talaat; Tarek A Salem
Journal:  J Clin Immunol       Date:  2011-10-07       Impact factor: 8.317

3.  PGE(2) -EP(2) signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF-κB.

Authors:  T Aoki; M Nishimura; T Matsuoka; K Yamamoto; T Furuyashiki; H Kataoka; S Kitaoka; R Ishibashi; A Ishibazawa; S Miyamoto; R Morishita; J Ando; N Hashimoto; K Nozaki; S Narumiya
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

4.  Cyclooxygenase-1-derived PGE2 promotes cell motility via the G-protein-coupled EP4 receptor during vertebrate gastrulation.

Authors:  Yong I Cha; Seok-Hyung Kim; Diane Sepich; F Gregory Buchanan; Lilianna Solnica-Krezel; Raymond N DuBois
Journal:  Genes Dev       Date:  2006-01-01       Impact factor: 11.361

5.  PAMAM dendrimers as nano carriers to investigate inflammatory responses induced by pulmonary exposure of PCB metabolites in Sprague-Dawley rats.

Authors:  Orarat Wangpradit; Andrea Adamcakova-Dodd; Katharina Heitz; Larry Robertson; Peter S Thorne; Gregor Luthe
Journal:  Environ Sci Pollut Res Int       Date:  2015-09-24       Impact factor: 4.223

Review 6.  Nothing but skin and bone.

Authors:  F Patrick Ross; Angela M Christiano
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

7.  Prostaglandin E2 receptors are differentially expressed in subpopulations of granulosa cells from primate periovulatory follicles.

Authors:  Siabhon M Harris; Lindsey C Aschenbach; Stephanie M Skinner; Brandy L Dozier; Diane M Duffy
Journal:  Biol Reprod       Date:  2011-07-13       Impact factor: 4.285

8.  Selective blockade of PGE2 EP1 receptor protects brain against experimental ischemia and excitotoxicity, and hippocampal slice cultures against oxygen-glucose deprivation.

Authors:  Abdullah Shafique Ahmad; Yun Tai Yun; Muzamil Ahmad; Takayuki Maruyama; Sylvain Doré
Journal:  Neurotox Res       Date:  2008-12       Impact factor: 3.911

9.  Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting.

Authors:  Youfei Guan; Yahua Zhang; Jing Wu; Zhonghua Qi; Guangrui Yang; Dou Dou; Yuansheng Gao; Lihong Chen; Xiaoyan Zhang; Linda S Davis; Mingfeng Wei; Xuefeng Fan; Monica Carmosino; Chuanming Hao; John D Imig; Richard M Breyer; Matthew D Breyer
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

10.  Reduced prostaglandin F2 alpha release from blood mononuclear leukocytes after oral supplementation of omega3 fatty acids: the OmegAD study.

Authors:  Inger Vedin; Tommy Cederholm; Yvonne Freund-Levi; Hans Basun; Erik Hjorth; Gerd Faxén Irving; Maria Eriksdotter-Jönhagen; Marianne Schultzberg; Lars-Olof Wahlund; Jan Palmblad
Journal:  J Lipid Res       Date:  2009-11-24       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.